NeuroMetrix, Inc. (NURO)
USD 4.47
(1.08%)
USD 4.47
(1.08%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.55 Million USD | -3.44% |
| 2022 | 1.61 Million USD | 128.57% |
| 2021 | 706.55 Thousand USD | -32.79% |
| 2020 | 1.05 Million USD | -9.66% |
| 2019 | 1.16 Million USD | -59.34% |
| 2018 | 2.86 Million USD | 108.95% |
| 2017 | 1.36 Million USD | 9.38% |
| 2016 | 1.25 Million USD | 14.98% |
| 2015 | 1.08 Million USD | 60.22% |
| 2014 | 679.74 Thousand USD | 20.73% |
| 2013 | 563.03 Thousand USD | -32.53% |
| 2012 | 834.52 Thousand USD | -52.68% |
| 2011 | 1.76 Million USD | -26.9% |
| 2010 | 2.41 Million USD | -47.08% |
| 2009 | 4.55 Million USD | -18.68% |
| 2008 | 5.6 Million USD | 4.72% |
| 2007 | 5.35 Million USD | 47.36% |
| 2006 | 3.63 Million USD | 35.4% |
| 2005 | 2.68 Million USD | 108.95% |
| 2004 | 1.28 Million USD | 19.09% |
| 2003 | 1.07 Million USD | 25.06% |
| 2002 | 862.31 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.45 Million USD | -1.43% |
| 2024 Q3 | 1.43 Million USD | -1.4% |
| 2024 Q1 | 1.47 Million USD | -5.64% |
| 2023 Q1 | 1.74 Million USD | 8.24% |
| 2023 FY | 1.55 Million USD | -3.44% |
| 2023 Q4 | 1.55 Million USD | -6.43% |
| 2023 Q3 | 1.66 Million USD | 5.22% |
| 2023 Q2 | 1.58 Million USD | -9.39% |
| 2022 FY | 1.61 Million USD | 128.57% |
| 2022 Q1 | 711.93 Thousand USD | 0.76% |
| 2022 Q2 | 869.37 Thousand USD | 22.11% |
| 2022 Q3 | 1.05 Million USD | 21.61% |
| 2022 Q4 | 1.61 Million USD | 52.76% |
| 2021 FY | 706.55 Thousand USD | -32.79% |
| 2021 Q4 | 706.55 Thousand USD | -29.13% |
| 2021 Q1 | 979.62 Thousand USD | -6.82% |
| 2021 Q2 | 1.02 Million USD | 5.06% |
| 2021 Q3 | 996.95 Thousand USD | -3.13% |
| 2020 Q2 | 1.19 Million USD | 3.33% |
| 2020 Q1 | 1.15 Million USD | -0.87% |
| 2020 Q3 | 1.05 Million USD | -11.89% |
| 2020 Q4 | 1.05 Million USD | 0.09% |
| 2020 FY | 1.05 Million USD | -9.66% |
| 2019 Q4 | 1.16 Million USD | 7.89% |
| 2019 Q2 | 2.06 Million USD | -17.27% |
| 2019 Q1 | 2.49 Million USD | -12.84% |
| 2019 FY | 1.16 Million USD | -59.34% |
| 2019 Q3 | 1.07 Million USD | -47.73% |
| 2018 FY | 2.86 Million USD | 108.95% |
| 2018 Q2 | 2.42 Million USD | 30.43% |
| 2018 Q1 | 1.85 Million USD | 35.7% |
| 2018 Q4 | 2.86 Million USD | 10.18% |
| 2018 Q3 | 2.59 Million USD | 7.14% |
| 2017 FY | 1.36 Million USD | 9.38% |
| 2017 Q4 | 1.36 Million USD | -23.32% |
| 2017 Q3 | 1.78 Million USD | 20.9% |
| 2017 Q2 | 1.47 Million USD | 23.43% |
| 2017 Q1 | 1.19 Million USD | -4.42% |
| 2016 Q4 | 1.25 Million USD | 7.75% |
| 2016 Q1 | 1.51 Million USD | 38.95% |
| 2016 Q2 | 1.04 Million USD | -30.74% |
| 2016 FY | 1.25 Million USD | 14.98% |
| 2016 Q3 | 1.16 Million USD | 10.89% |
| 2015 Q2 | 1.22 Million USD | 92.33% |
| 2015 FY | 1.08 Million USD | 60.22% |
| 2015 Q4 | 1.08 Million USD | 1.58% |
| 2015 Q3 | 1.07 Million USD | -12.23% |
| 2015 Q1 | 635.16 Thousand USD | -6.56% |
| 2014 Q2 | 604.06 Thousand USD | -9.26% |
| 2014 Q4 | 679.74 Thousand USD | 7.85% |
| 2014 FY | 679.74 Thousand USD | 20.73% |
| 2014 Q1 | 665.69 Thousand USD | 18.23% |
| 2014 Q3 | 630.23 Thousand USD | 4.33% |
| 2013 Q2 | 753.94 Thousand USD | -5.12% |
| 2013 Q3 | 544.21 Thousand USD | -27.82% |
| 2013 Q4 | 563.03 Thousand USD | 3.46% |
| 2013 FY | 563.03 Thousand USD | -32.53% |
| 2013 Q1 | 794.66 Thousand USD | -4.78% |
| 2012 Q2 | 1.07 Million USD | -11.47% |
| 2012 Q3 | 787.82 Thousand USD | -26.86% |
| 2012 Q4 | 834.52 Thousand USD | 5.93% |
| 2012 Q1 | 1.21 Million USD | -31.02% |
| 2012 FY | 834.52 Thousand USD | -52.68% |
| 2011 FY | 1.76 Million USD | -26.9% |
| 2011 Q1 | 2 Million USD | -16.76% |
| 2011 Q4 | 1.76 Million USD | -11.94% |
| 2011 Q3 | 2 Million USD | 15.12% |
| 2011 Q2 | 1.73 Million USD | -13.38% |
| 2010 FY | 2.41 Million USD | -47.08% |
| 2010 Q3 | 4.5 Million USD | -7.98% |
| 2010 Q4 | 2.41 Million USD | -46.39% |
| 2010 Q2 | 4.89 Million USD | -1.75% |
| 2010 Q1 | 4.97 Million USD | 9.19% |
| 2009 Q1 | 5.12 Million USD | -8.67% |
| 2009 FY | 4.55 Million USD | -18.68% |
| 2009 Q4 | 4.55 Million USD | -6.82% |
| 2009 Q3 | 4.89 Million USD | -3.24% |
| 2009 Q2 | 5.05 Million USD | -1.25% |
| 2008 Q2 | 6.14 Million USD | 2.88% |
| 2008 Q1 | 5.97 Million USD | 11.56% |
| 2008 Q4 | 5.6 Million USD | -11.16% |
| 2008 Q3 | 6.31 Million USD | 2.7% |
| 2008 FY | 5.6 Million USD | 4.72% |
| 2007 Q3 | 4.97 Million USD | -4.12% |
| 2007 Q1 | 4.61 Million USD | 27.0% |
| 2007 FY | 5.35 Million USD | 47.36% |
| 2007 Q4 | 5.35 Million USD | 7.71% |
| 2007 Q2 | 5.18 Million USD | 12.36% |
| 2006 Q1 | 3.03 Million USD | 13.16% |
| 2006 Q2 | 2.94 Million USD | -3.02% |
| 2006 Q3 | 2.81 Million USD | -4.3% |
| 2006 Q4 | 3.63 Million USD | 28.93% |
| 2006 FY | 3.63 Million USD | 35.4% |
| 2005 Q1 | 1.49 Million USD | 16.74% |
| 2005 FY | 2.68 Million USD | 108.95% |
| 2005 Q4 | 2.68 Million USD | 26.39% |
| 2005 Q3 | 2.12 Million USD | 5.2% |
| 2005 Q2 | 2.01 Million USD | 34.61% |
| 2004 Q2 | 1.09 Million USD | -16.41% |
| 2004 Q3 | 1.32 Million USD | 20.72% |
| 2004 FY | 1.28 Million USD | 19.09% |
| 2004 Q4 | 1.28 Million USD | -3.0% |
| 2004 Q1 | 1.31 Million USD | 21.66% |
| 2003 FY | 1.07 Million USD | 25.06% |
| 2003 Q4 | 1.07 Million USD | 0.0% |
| 2002 FY | 862.31 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | 52.887% |
| BrainsWay Ltd. | 3.71 Million USD | 58.046% |
| Cerus Corporation | 39.86 Million USD | 96.089% |
| Envoy Medical, Inc. | 1.4 Million USD | -11.07% |
| electroCore, Inc. | 2.16 Million USD | 27.804% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -241.232% |
| IceCure Medical Ltd | 2.27 Million USD | 31.454% |
| Inogen, Inc. | 21.84 Million USD | 92.86% |
| OrthoPediatrics Corp. | 105.85 Million USD | 98.527% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -460.945% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -155942700.0% |
| MaxCyte, Inc. | 12.22 Million USD | 87.248% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | 9.687% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -896.949% |
| Orthofix Medical Inc. | 222.16 Million USD | 99.298% |
| PAVmed Inc | 1.01 Million USD | -53.336% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 92.188% |
| RxSight, Inc. | 17.42 Million USD | 91.049% |
| Sight Sciences, Inc. | 7.84 Million USD | 80.132% |
| SI-BONE, Inc. | 20.24 Million USD | 92.299% |
| TELA Bio, Inc. | 13.16 Million USD | 88.152% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 94.668% |
| Vivos Therapeutics, Inc. | 1.00 USD | -155942700.0% |
| Acutus Medical, Inc. | 4.27 Million USD | 63.548% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -578.012% |
| Nano-X Imaging Ltd. | 2.35 Million USD | 33.81% |
| CVRx, Inc. | 10.98 Million USD | 85.801% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -299.775% |
| Bioventus Inc. | 91.33 Million USD | 98.293% |
| Venus Concept Inc. | 28.67 Million USD | 94.562% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | 38.726% |
| LivaNova PLC | 147.88 Million USD | 98.946% |
| 908 Devices Inc. | 14.93 Million USD | 89.561% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 98.86% |
| Nemaura Medical Inc. | 1.75 Million USD | 11.136% |
| NeuroPace, Inc. | 11.21 Million USD | 86.094% |
| LENSAR, Inc. | 15.68 Million USD | 90.06% |
| Apyx Medical Corporation | 9.92 Million USD | 84.285% |
| Cutera, Inc. | 72.1 Million USD | 97.837% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | 41.66% |
| BioSig Technologies, Inc. | -103 Thousand USD | 1614.008% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 96.638% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | 80.288% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 99.6% |
| Axonics, Inc. | 79.94 Million USD | 98.049% |
| Outset Medical, Inc. | 49.21 Million USD | 96.831% |
| IRIDEX Corporation | 9.9 Million USD | 84.258% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 96.078% |
| IRadimed Corporation | 12.82 Million USD | 87.837% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -106.274% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -489.56% |
| Telesis Bio, Inc. | 4.02 Million USD | 61.256% |
| Viemed Healthcare, Inc. | 4.6 Million USD | 66.131% |
| Varex Imaging Corporation | 277.5 Million USD | 99.438% |
| Quipt Home Medical Corp. | 18.32 Million USD | 91.491% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 90.686% |
| Dynatronics Corporation | 5.59 Million USD | 72.123% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | 58.315% |
| Semler Scientific, Inc. | 445 Thousand USD | -250.433% |
| InMode Ltd. | 45.09 Million USD | 96.542% |
| Bruker Corporation | 968.3 Million USD | 99.839% |
| Cytosorbents Corporation | 3.68 Million USD | 57.626% |
| DexCom, Inc. | 559.6 Million USD | 99.721% |
| Align Technology, Inc. | 296.9 Million USD | 99.475% |
| Viveve Medical, Inc. | 1.47 Million USD | -5.939% |
| ZimVie Inc. | 79.6 Million USD | 98.041% |
| Movano Inc. | 1.51 Million USD | -3.069% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 97.438% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -896.949% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 99.013% |
| Profound Medical Corp. | 6.95 Million USD | 77.573% |
| Insulet Corporation | 402.6 Million USD | 99.613% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 89.491% |
| iCAD, Inc. | 917 Thousand USD | -70.058% |
| Nuwellis, Inc. | 1.99 Million USD | 21.911% |
| Biotricity, Inc. | 1.87 Million USD | 17.025% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 88.84% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | 25.953% |
| PAVmed Inc. | 1.01 Million USD | -53.336% |
| BIOLASE, Inc. | 11.43 Million USD | 86.36% |
| Beyond Air, Inc. | 2.12 Million USD | 26.684% |
| FONAR Corporation | 2.71 Million USD | 42.572% |
| AxoGen, Inc. | 23.02 Million USD | 93.226% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 93.078% |
| Inari Medical, Inc. | 42.9 Million USD | 96.365% |
| UFP Technologies, Inc. | 70.19 Million USD | 97.778% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -147.851% |
| Tenon Medical, Inc. | 554 Thousand USD | -181.485% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | 6.325% |
| AdaptHealth Corp. | 113.64 Million USD | 98.628% |
| Sintx Technologies, Inc. | 888 Thousand USD | -75.611% |
| NanoVibronix, Inc. | 2.73 Million USD | 42.92% |
| Quanterix Corporation | 22.36 Million USD | 93.027% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 89.497% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 97.249% |
| TransMedics Group, Inc. | 44.23 Million USD | 96.475% |
| ReWalk Robotics Ltd. | 5.65 Million USD | 72.414% |
| Hyperfine, Inc. | 6.58 Million USD | 76.308% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 98.049% |
| Biomerica, Inc. | 2.37 Million USD | 34.368% |
| Bone Biologics Corporation | -328.84 Thousand USD | 574.215% |
| AVITA Medical, Inc. | 3.12 Million USD | 50.041% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 94.78% |